Back to news

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Business Wire•30/07/2026•06:45 ET
0
Whiz Insights

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in